Premium
Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations
Author(s) -
Caminsky Natasha G.,
Mucaki Eliseos J.,
Perri Ami M.,
Lu Ruipeng,
Knoll Joan H. M.,
Rogan Peter K.
Publication year - 2016
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.22972
Subject(s) - biology , genetics , msh2 , frameshift mutation , gene , msh6 , rna splicing , chek2 , germline mutation , computational biology , exon , mutation , dna mismatch repair , rna , dna repair
BRCA1 and BRCA2 testing for hereditary breast and ovarian cancer (HBOC) does not identify all pathogenic variants. Sequencing of 20 complete genes in HBOC patients with uninformative test results ( N = 287), including noncoding and flanking sequences of ATM , BARD1 , BRCA1 , BRCA2 , CDH1 , CHEK2 , EPCAM , MLH1 , MRE11A , MSH2 , MSH6 , MUTYH , NBN , PALB2 , PMS2 , PTEN , RAD51B , STK11 , TP53 , and XRCC2 , identified 38,372 unique variants. We apply information theory (IT) to predict and prioritize noncoding variants of uncertain significance in regulatory, coding, and intronic regions based on changes in binding sites in these genes. Besides mRNA splicing, IT provides a common framework to evaluate potential affinity changes in transcription factor (TFBSs), splicing regulatory (SRBSs), and RNA‐binding protein (RBBSs) binding sites following mutation. We prioritized variants affecting the strengths of 10 splice sites (four natural, six cryptic), 148 SRBS, 36 TFBS, and 31 RBBS. Three variants were also prioritized based on their predicted effects on mRNA secondary (2°) structure and 17 for pseudoexon activation. Additionally, four frameshift, two in‐frame deletions, and five stop‐gain mutations were identified. When combined with pedigree information, complete gene sequence analysis can focus attention on a limited set of variants in a wide spectrum of functional mutation types for downstream functional and co‐segregation analysis.